Muhammad Akbar Ramadhan Munandar, Hendra Priatna Munandar, and Liana Herlina, “Cost-Effectiveness of Pembrolizumab as First-Line Treatment for PD-L1 Positive NSCLC: A Systematic Review”, the int. j. of med. science and health, vol. 23, no. 2, pp. 64–130, Jan. 2026, doi: 10.70070/h3zdy035.